Palisades Compounding Pharmacy

Form 483 issued March 15, 2023 · Pacific Palisades, California

Inspection
Feb 23 – Mar 15, 2023
Investigator
Darren S. Brown
Observations
2
Pages
3
FEI number
3008174851

In short: On March 15, 2023, FDA issued a Form 483 with 2 observations to Palisades Compounding Pharmacy in Pacific Palisades, California (FEI 3008174851) after an inspection that ran Feb 23 – Mar 15, 2023. The investigator was Darren S. Brown. Most observations concern materials; the most-cited regulation is 21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures).

At a glance

Observations span 1 system, led by materials.

Materials1
Other1

Most cited: FDCA 501(a)(2)(A) (1×) · 211.84 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01
    FDCA 501(a)(2)(A)

    You produced hazardous drngs without providing adequate segregation, cleaning of work surfaces and cleaning of…

  2. 02

    Your fnm released diug product in which the strength differs from, or its purity or quality…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Palisades Compounding Pharmacy?

FDA listed 2 observations on this Form 483, mostly about materials. The most-cited regulation is 21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures). The opening words of each observation are shown on this page.

Who inspected Palisades Compounding Pharmacy?

Darren S. Brown is named on this Form 483, for the inspection of Feb 23 – Mar 15, 2023. Each investigator has a profile showing what they cite most.

When was Palisades Compounding Pharmacy inspected by FDA?

The inspection ran Feb 23 – Mar 15, 2023, and the Form 483 is dated March 15, 2023.

How do I get the full Form 483 for Palisades Compounding Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free